z-logo
open-access-imgOpen Access
Ablation of HRC alleviates cardiac arrhythmia and improves abnormal Ca handling in CASQ2 knockout mice prone to CPVT
Author(s) -
Bin Liu,
HsiangTing Ho,
Lucia Brunello,
Sathya D. Unudurthi,
Qing Lou,
Andriy E. Belevych,
Lan Qian,
Do Han Kim,
Chunghee Cho,
Paul M.L. Janssen,
Thomas J. Hund,
Björn C. Knollmann,
Evangelia G. Kranias,
Sándor Györke
Publication year - 2015
Publication title -
cardiovascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvv222
Subject(s) - calsequestrin , ryanodine receptor 2 , catecholaminergic polymorphic ventricular tachycardia , ryanodine receptor , knockout mouse , medicine , endocrinology , refractory period , endoplasmic reticulum , diastole , myocyte , cardiac function curve , phenotype , receptor , chemistry , biology , microbiology and biotechnology , heart failure , biochemistry , blood pressure , gene
Cardiac calsequestrin (CASQ2) and histidine-rich Ca-binding protein (HRC) are sarcoplasmic reticulum (SR) Ca-binding proteins that regulate SR Ca release in mammalian heart. Deletion of either CASQ2 or HRC results in relatively mild phenotypes characterized by preserved cardiac structure and function, although CASQ2 knockout (KO), or Cnull, shows increased arrhythmia burden under conditions of catecholaminergic stress. We hypothesized that given the apparent overlap of functions of CASQ2 and HRC, simultaneous ablation of both would deteriorate the cardiac phenotype compared with the single knockouts.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom